Out licensing and Partnership Opportunities


Eukarÿs core business covers synthetic gene therapy and bioproduction tools. Given it strong C3P3 patent portfolio, Eukarÿs offers the opportunity for specialized third-party companies to take a license on some of its technology components for the development of applications not pursued by Eukarÿs. These applications comprise bioassays, vaccination, bioproduction and others.

If you want to discuss out licensing and partnership opportunities.

Eukarÿs SAS – Génopole campus

4 rue Pierre Fontaine

921058 Evry Cedex